Let’s start up with the current stock price of AcelRx Pharmaceuticals Inc. (ACRX), which is $0.93 to be very precise. The Stock rose vividly during the last session to $1.18 after opening rate of $1.17 while the lowest price it went was recorded $1.06 before closing at $1.10.Recently in News on March 14, 2023, AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals. Agreement with Alora Pharmaceuticals provides AcelRx with 15% royalties on commercial sales, 75% royalties on Department of Defense (DoD) sales, up to $116.5 million in potential sales-based milestone payments, and a strong commercial partner experienced with commercialization in hospital settings. You can read further details here
AcelRx Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.6780 on 03/18/22, with the lowest value was $0.8900 for the same time period, recorded on 03/14/23.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
AcelRx Pharmaceuticals Inc. (ACRX) full year performance was -86.43%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AcelRx Pharmaceuticals Inc. shares are logging -87.89% during the 52-week period from high price, and -12.26% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.06 and $7.68.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1602806 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AcelRx Pharmaceuticals Inc. (ACRX) recorded performance in the market was -58.85%, having the revenues showcasing -55.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 8.02M, as it employees total of 43 workers.
The Analysts eye on AcelRx Pharmaceuticals Inc. (ACRX)
During the last month, 0 analysts gave the AcelRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.1512, with a change in the price was noted -3.68. In a similar fashion, AcelRx Pharmaceuticals Inc. posted a movement of -79.92% for the period of last 100 days, recording 176,823 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ACRX is recording 0.29 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of AcelRx Pharmaceuticals Inc. (ACRX)
Raw Stochastic average of AcelRx Pharmaceuticals Inc. in the period of last 50 days is set at 1.79%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 3.99%. In the last 20 days, the company’s Stochastic %K was 6.71% and its Stochastic %D was recorded 6.64%.
Considering, the past performance of AcelRx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -58.85%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -81.50%, alongside a downfall of -86.43% for the period of the last 12 months. The shares increased approximately by -23.14% in the 7-day charts and went up by -47.16% in the period of the last 30 days. Common stock shares were lifted by -55.71% during last recorded quarter.
